Related Experiment Video
Updated: Feb 19, 2026
Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
Published on: August 29, 2018
Disease of mRNA Regulation: Relevance for Ischemic Brain Injury
1Department of Physiology, and the Center for Molecular Medicine and Genetics, Wayne State University, 4116 Scott Hall, 540 E. Canfield, Detroit, MI, 48201, USA. ddegraci@med.wayne.edu.
Abstract:
In this mini-review we give an overview of the role of mRNA-binding proteins and their associated messenger ribonucleoprotein complexes (mRNPs) in several disease states, and bring this information to bear on the pathophysiology of brain ischemia. One conclusion reached is that mRNPs may play a causal role in proteotoxicity instead of being merely passive targets. Ischemia therapies targeting mRNPs have advantages over targeting single pathways, but the behavior of mRNPs needs to be considered in the design of therapies.
Insights
Messenger ribonucleoprotein complexes (mRNPs) are implicated in brain ischemia and proteotoxicity. Targeting mRNPs offers therapeutic advantages over single pathways for ischemia treatment.
Area of Science:
- Molecular Biology
- Neuroscience
- Pathophysiology
Background:
- Messenger ribonucleoprotein complexes (mRNPs) are crucial for gene expression regulation.
- Dysregulation of mRNPs is linked to various disease states.
- The specific role of mRNPs in brain ischemia pathophysiology requires further elucidation.
Purpose of the Study:
- To review the role of mRNA-binding proteins and mRNPs in disease.
- To apply this knowledge to the pathophysiology of brain ischemia.
- To explore the potential of mRNPs as therapeutic targets for ischemia.
Main Methods:
- Mini-review of existing literature on mRNA-binding proteins and mRNPs.
- Analysis of mRNP involvement in proteotoxicity.
- Discussion of therapeutic strategies targeting mRNPs in ischemia.
Main Results:
- mRNPs may actively contribute to proteotoxicity in disease, not just as targets.
- Ischemia therapies focused on mRNPs present potential benefits over single-pathway approaches.
- Understanding mRNP behavior is critical for designing effective ischemia therapies.
Conclusions:
- mRNPs play a significant role in the pathophysiology of brain ischemia.
- Targeting mRNPs offers a promising therapeutic avenue for ischemia.
- Future therapeutic strategies must consider the complex behavior of mRNPs.
More Related Videos
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
09:29Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury
Published on: September 11, 2017
Related Concept Videos
02:22Regulated mRNA Transport
02:22Regulated mRNA Transport
00:49The Blood-brain Barrier
01:31Translation
Translation Produces the Building Blocks of Life
Proteins are...
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
02:24Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...